Company: VRCA
Filing Date: 2025-07-23
Form Type: 8-K
Source: 0001193125-25-162939
Chunk: 2

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-07-23
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

(d)  Exhibits

  Exhibit      Exhibit Title or Description                                                                                       
      No.                                                                                                                         
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      3.1      Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Verrica Pharmaceuticals Inc.  
      104      Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)           

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                           Verrica Pharmaceuticals Inc.     
  Date: July 23, 2025      /s/ John J. Kirby                
                           John J. Kirby                    
                           Interim Chief Financial Officer